Samantha McLemore - Patient Capital Management,
Holding/activity history for NVIDIA Corp. (NVDA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 711,115 | 4.62 | Add 11.32% | 0.47 | $174.40 | $124,018,525 | SEC |
| 2025 Q4 | 638,814 | 4.60 | Add 0.97% | 0.04 | $186.50 | $119,138,794 | SEC |
| 2025 Q3 | 632,684 | 4.73 | Reduce 0.23% | 0.01 | $186.58 | $118,046,253 | SEC |
| 2025 Q2 | 634,173 | 4.52 | Add 1.15% | 0.05 | $157.99 | $100,192,915 | SEC |
| 2025 Q1 | 626,952 | 3.49 | Add 3.02% | 0.10 | $108.38 | $67,949,071 | SEC |
| 2024 Q4 | 608,563 | 3.77 | Reduce 0.03% | <0.01 | $134.29 | $81,723,891 | SEC |
| 2024 Q3 | 608,728 | 3.63 | Add 0.48% | 0.02 | $121.44 | $73,923,879 | SEC |
| 2024 Q2 | 605,839 | 3.98 | Add 899.64% | 3.58 | $123.54 | $74,845,305 | SEC |
| 2024 Q1 | 60,606 | 2.67 | Buy | 2.67 | $903.56 | $54,761,028 | SEC |